Skip to main content
  • AACR Publications
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

  • Register
  • Log in
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Focus on Computer Resources
    • 75th Anniversary
    • Meeting Abstracts
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citations
    • Author/Keyword
  • News
    • Cancer Discovery News
  • AACR Publications
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in

Search

  • Advanced search
Cancer Research
Cancer Research

Advanced Search

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Focus on Computer Resources
    • 75th Anniversary
    • Meeting Abstracts
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citations
    • Author/Keyword
  • News
    • Cancer Discovery News
Articles

Combination versus Sequential Five-Drug Chemotherapy in Metastatic Carcinoma of the Breast

Richard V. Smalley, Scott Murphy, Charles M. Huguley Jr. and Alfred A. Bartolucci
Richard V. Smalley
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Scott Murphy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Charles M. Huguley
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alfred A. Bartolucci
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI:  Published November 1976
  • Article
  • Info & Metrics
  • PDF
Loading

Summary

Patients with metastatic or recurrent adenocarcinoma of the breast were randomized to weekly combination chemotherapy, intermittent combination chemotherapy, or singledrug chemotherapy administered sequentially. Patients receiving weekly combination therapy were more likely to respond than those receiving single-drug therapy (5-fluorouracil). The median survival for either group treated with combination therapy was double that of patients on sequential therapy. One-fourth of the patients had a prolonged survival (>75 weeks), regardless of therapy.

Footnotes

  • ↵1 This investigation was supported by the following USPHS Research Grants from the National Cancer Institute to the following institutions: CA03227 and CA11263 to Emory University School of Medicine, Atlanta, Ga.; CA06807 to Medical College of Georgia, Augusta, Ga.; CA05641 to University of Miami School of Medicine, Miami, Fla.; CA12639 to Presbyterian-University of Pennsylvania Medical Center, Philadelphia, Pa.; CA07961 to Temple University School of Medicine, Philadelphia, Pa.; CA03376 to Washington University School of Medicine, St. Louis, Mo.; CA12223 to University of Puerto Rico School of Medicine, San Juan, Puerto Rico; CA13237 to University of Tennessee Memorial Research Center, Knoxville, Tenn.; CA13249 to Veterans Administration Hospital, New Orleans, La.; CA15584 to Case Western Reserve School of Medicine-Veterans Administration Hospital, Cleveland, Ohio; CA17027 to University of Tennessee School of Medicine, Memphis, Tenn; CA17214 to St. Louis University School of Medicine, St. Louis, Mo.; and CA116389 to University of Louisville School of Medicine, Louisville, Ky.

  • ↵2 To whom requests for reprints should be addressed.

  • ↵3 The following members of the Southeastern Cancer Study Group participated in this study: Evert A. Bruckner, Alfred A. Bartolucci, Yick-Kwong Chan, Charles C. Corley, Jr., Charles M. Huguley, Jr., James W. Keller, John D. Schmale, William Ralph Vogler, and William H. Whaley, Emory University School of Medicine, Atlanta, Ga.; Morton Berenson, Medical College of Georgia, Augusta, Ga.; Howard E. Lessner, University of Miami School of Medicine, Miami, Fla.; Scott Murphy, Presbyterian-University of Pennsylvania Medical Center, Philadelphia, Pa.; Richard V. Smalley, Temple University School of Medicine, Philadelphia, Pa.; Virgil Loeb, Jr., Washington University School of Medicine, St. Louis, Mo.; Antonio Grillo and Enrique Velez-Garcia, University of Puerto Rico School of Medicine, San Juan, Puerto Rico; Stephen Krauss, University of Tennessee Memorial Research Center, Knoxville, Tenn.; Karl Tornyos, Veterans Administration Hospital, New Orleans, La.; Robert Kellermeyer and Anne Rassiga, Case Western Reserve University School of Medicine and Veterans Administration Hospital, Cleveland, Ohio; Stanley Lowenbraun, University School of Medicine, Louisville, Ky.; Charles L. Neely, University of Tennessee School of Medicine, Memphis, Tenn.; and Goronwy O. Broum, Jr., St. Louis University School of Medicine, St. Louis, Mo.

  • Received April 16, 1976.
  • Accepted July 15, 1976.
  • ©1976 American Association for Cancer Research.
PreviousNext
Back to top
November 1976
Volume 36, Issue 11 Part 1
  • Table of Contents
  • Table of Contents (PDF)
  • Index by Author
  • Editorial Board (PDF)
  • Front Matter (PDF)

Sign up for alerts

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Research article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Combination versus Sequential Five-Drug Chemotherapy in Metastatic Carcinoma of the Breast
(Your Name) has forwarded a page to you from Cancer Research
(Your Name) thought you would be interested in this article in Cancer Research.
Citation Tools
Combination versus Sequential Five-Drug Chemotherapy in Metastatic Carcinoma of the Breast
Richard V. Smalley, Scott Murphy, Charles M. Huguley Jr. and Alfred A. Bartolucci
Cancer Res November 1 1976 (36) (11 Part 1) 3911-3916;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Combination versus Sequential Five-Drug Chemotherapy in Metastatic Carcinoma of the Breast
Richard V. Smalley, Scott Murphy, Charles M. Huguley Jr. and Alfred A. Bartolucci
Cancer Res November 1 1976 (36) (11 Part 1) 3911-3916;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • The Role of Chimeric Paired Box Transcription Factors in the Pathogenesis of Pediatric Rhabdomyosarcoma
  • The Effect of Chromosomal Translocations in Acute Leukemias: The LMO2 Paradigm in Transcription and Development
  • Laureate Citations
Show more Articles
  • Home
  • Alerts
  • Feedback
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians
  • Reviewers

About Cancer Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2018 by the American Association for Cancer Research.

Cancer Research Online ISSN: 1538-7445
Cancer Research Print ISSN: 0008-5472
Journal of Cancer Research ISSN: 0099-7013
American Journal of Cancer ISSN: 0099-7374

Advertisement